Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
IPO Year: 1992
Exchange: NASDAQ
Website: pattersoncompanies.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/4/2024 | $23.00 | Neutral | Mizuho |
| 2/29/2024 | $34.00 → $28.00 | Overweight → Neutral | Piper Sandler |
| 2/26/2024 | $36.00 | Outperform | Leerink Partners |
| 5/13/2022 | $36.00 | Outperform | Credit Suisse |
| 3/3/2022 | $30.00 → $32.00 | Equal-Weight | Morgan Stanley |
| 1/31/2022 | $30.00 | Equal-Weight | Morgan Stanley |
| 10/1/2021 | $38.00 | Outperform | Credit Suisse |
NEW YORK, April 14, 2025 /PRNewswire/ -- Sterling Infrastructure Inc. (NASD: STRL) will replace Patterson Companies Inc. (NASD: PDCO) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 17. Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 17, 2025 S&P SmallCap 600 Addition Sterling Infrastructure STRL Industrials April 17, 2025 S&P SmallCap 600 Deletion Patterson Companies PDCO Health Care Fo
Patterson Companies, Inc. (NASDAQ:PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, "I would like to express my gratitude to the Patterson shareholders for their support today, and throughout this transaction process. The Patterson team is excited about this partnership with Patient Square Capital and beginning our next chapter as a private company. We be
Third quarter reported net sales decreased 2.7 percent year-over-year to $1.57 billion, and internal sales decreased 2.4 percent. Delivered third quarter GAAP earnings of $0.35 per diluted share and adjusted earnings1 of $0.43 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $119.2 million to shareholders in the form of cash dividends and share repurchases through the first nine months of fiscal 2025. Patterson Companies, Inc. (NASDAQ:PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. "As we continue to progress toward cl
Transaction Is Expected to Close in April 2025 Patterson Companies, Inc. (NASDAQ:PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day "go-shop" period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. ("Patient Square"), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson's receivables facilities. The "go-shop" period expired at 11:59 p.m. (Central Time) on January 19, 2025. Pursuant to the merger agreement, Patterson and its representa
Valued at Approximately $4.1 Billion Patterson Companies, Inc. (NASDAQ:PDCO), a leading dental and animal health distributor, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated health care investment firm. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson's 30 calendar day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives), or a transaction value of approximately $4.1 billion, including the refinancing of
Patterson Approved Vendor status will pave the way for customers to securely use new payments capabilities. VALHALLA, N.Y., Dec. 10, 2024 /PRNewswire/ -- Rectangle Health, a leading provider of innovative payment solutions for healthcare providers, today announced integrations with Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (NASDAQ:PDCO). The approved integrations with Patterson Dental's industry-leading practice management software solutions – Dolphin Management, Fuse, and Eaglesoft – aim to streamline payment processes and enhance the financial experience for dental practices and their patients.
Second quarter reported net sales increased 1.3 percent year-over-year to $1.67 billion, and internal sales increased 0.6 percent. Delivered second quarter GAAP earnings of $0.30 per diluted share and adjusted earnings1 of $0.47 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $96.2 million to shareholders in the form of cash dividends and share repurchases through the first six months of fiscal 2025. Revises fiscal 2025 GAAP earnings guidance range to $1.83 to $1.93 per diluted share and adjusted earnings1 guidance range to $2.25 to $2.35 per diluted share. Company
Patterson Companies (NASDAQ:PDCO) today announced that it will hold its fiscal 2025 second-quarter conference call on Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. An audio replay of the fiscal 2025 second-quarter conference call will also be available for one week. To access the audio replay, please pre-register at https://registrations.events/direct/Q4I672812531 to receive a unique access code to access and listen to the audio playback. About Patterson Companies Inc. Pa
Patterson Dental remains the premier distributor for PDS Health's network of over 1,000 supported practices across the United States, providing equipment, services, technology and more Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (NASDAQ:PDCO), today announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization formerly known as Pacific Dental Services, to extend their strategic relationship through the end of 2027. The extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS Health's network of more than 1,000 supported pra
Kristin Dietzler Named Dental President Patterson Companies Inc. (NASDAQ:PDCO) announced the appointment of Kristin Dietzler as Patterson Dental's North American president. Dietzler brings extensive expertise in adjacent healthcare companies with a proven track record of success in optimizing results. She will report to Kevin Pohlman, chief operating officer of Patterson Companies, and she will be a member of the company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241023782217/en/Kristin Dietzler Named Patterson Dental President (Photo: Business Wire) Dietzler joins Patterson Dental with nearly 30
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
4 - PATTERSON COMPANIES, INC. (0000891024) (Issuer)
Mizuho initiated coverage of Patterson Companies with a rating of Neutral and set a new price target of $23.00
Piper Sandler downgraded Patterson Companies from Overweight to Neutral and set a new price target of $28.00 from $34.00 previously
Leerink Partners initiated coverage of Patterson Companies with a rating of Outperform and set a new price target of $36.00
Credit Suisse resumed coverage of Patterson Companies with a rating of Outperform and set a new price target of $36.00
Morgan Stanley reiterated coverage of Patterson Companies with a rating of Equal-Weight and set a new price target of $32.00 from $30.00 previously
Morgan Stanley initiated coverage of Patterson Companies with a rating of Equal-Weight and set a new price target of $30.00
Credit Suisse resumed coverage of Patterson Companies with a rating of Outperform and set a new price target of $38.00
Piper Sandler upgraded Patterson Companies from Neutral to Overweight and set a new price target of $44.00 from $34.00 previously
15-12G - PATTERSON COMPANIES, INC. (0000891024) (Filer)
8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)
S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)
S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)
S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)
S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)
S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)
8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)
8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)
DEFA14A - PATTERSON COMPANIES, INC. (0000891024) (Filer)